Source link : https://newshealth.biz/health-news/gene-therapy-shows-5-year-success/
TOPLINE: A single intravenous dose of etranacogene dezaparvovec gene therapy maintained factor IX (FIX) activity at 45.7 IU/dL after 5 years in patients with hemophilia B, eliminating the need for prophylaxis with no late-emergent safety events. METHODOLOGY: Researchers conducted a phase 2b, open-label, single-arm, multicenter trial evaluating a single intravenous dose (2 × 1013 genome […]
The post Gene Therapy Shows 5-Year Success first appeared on News Health.
—-
Author : News Health
Publish date : 2025-07-25 06:04:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8